Published in Anticancer Res on August 17, 2000
Gynaecological cancer follow-up: national survey of current practice in the UK. BMJ Open (2013) 0.85
Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up. Int J Clin Oncol (2010) 0.77
Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors. Obstet Gynecol (2016) 0.75
Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion. Lancet (1969) 2.04
An increased vulnerability to stress is associated with a poor outcome of in vitro fertilization-embryo transfer treatment. Fertil Steril (1997) 1.75
Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J (1990) 1.73
A comparison of ultrasonography and magnetic resonance imaging in the evaluation of temporomandibular joint involvement in rheumatoid arthritis and psoriatic arthritis. Rheumatology (Oxford) (2003) 1.61
Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.58
Maternal hyperoxygenation in the treatment of intrauterine growth retardation. Am J Obstet Gynecol (1992) 1.55
Influence of age and sex on serum concentrations of total dimeric activin A. Eur J Endocrinol (1998) 1.54
Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab (1997) 1.54
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol (2001) 1.51
Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med (1992) 1.41
Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Br J Obstet Gynaecol (1999) 1.40
Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.39
Modifications in uterine and intraovarian artery impedance in cycles of treatment with exogenous gonadotropins: effects of luteal phase support. Fertil Steril (1995) 1.39
The association of menstrual migraine with the premenstrual syndrome. Cephalalgia (1993) 1.39
A personal initiative for women's health: to challenge the Women's Health Initiative. Gynecol Endocrinol (2002) 1.38
Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas (2001) 1.22
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer (1997) 1.21
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer (2007) 1.20
Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects. Neuroendocrinology (1980) 1.19
Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev (1996) 1.19
Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol (1985) 1.16
Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab (2000) 1.16
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. Epilepsia (1985) 1.14
Human chorionic somatomammotrophin radioimmunoassay in evaluation of placental function. J Obstet Gynaecol Br Commonw (1971) 1.14
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gynecol Oncol (1995) 1.12
Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res (2000) 1.12
Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Invest (2000) 1.10
Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab (1999) 1.10
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer (2007) 1.04
Parotid sialography and minor salivary gland biopsy in the diagnosis of Sjögren's syndrome. A comparative study of 84 patients. J Rheumatol (1988) 1.03
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol (2002) 1.03
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03
Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease. Clin Microbiol Infect (2009) 1.02
Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas (1993) 1.02
Ankyloglossia: a morphofunctional investigation in children. Oral Dis (2005) 1.01
Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer. Int J Gynecol Cancer (2008) 1.00
Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol (1991) 1.00
Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol (1999) 1.00
Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. Eur J Endocrinol (1998) 1.00
Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol (2000) 0.99
Serum allopregnanolone in women with postpartum "blues". Obstet Gynecol (2001) 0.98
The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: a CTF study. Gynecol Oncol (1996) 0.97
Steroid hormones and BDNF. Neuroscience (2013) 0.96
Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metab (1982) 0.96
High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod (2000) 0.95
Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int (2001) 0.95
Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr Res (1999) 0.95
Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract Res Clin Endocrinol Metab (2003) 0.95
Human chorionic somatomammotropin (HCS) plasma levels in normal and pathological pregnancies and their correlation with the placental function. Acta Endocrinol Suppl (Copenh) (1972) 0.94
Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am J Obstet Gynecol (1996) 0.94
Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. Mol Hum Reprod (2010) 0.94
Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol (2000) 0.94
Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin. J Steroid Biochem Mol Biol (2006) 0.94
Relationship between human oocyte maturity, fertilization and follicular fluid growth factors. Hum Reprod (1994) 0.93
Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosom Med (2001) 0.93
Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension (1997) 0.92
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer. Eur J Cancer (1994) 0.92
In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels. Mol Hum Reprod (2001) 0.92
Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1). Eur Heart J (1989) 0.91
Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts. Acta Endocrinol (Copenh) (1984) 0.91
Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci (1993) 0.91
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle. J Endocrinol Invest (1995) 0.90
Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. Gynecol Endocrinol (1995) 0.90
Fertility drugs and ovarian cancer. Gynecol Endocrinol (1997) 0.90
Oral discomfort and hormone replacement therapy in the post-menopause. Maturitas (1991) 0.89
Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study. Gynecol Oncol (1998) 0.89
Hypothalamus-pituitary-adrenal axis of heroin addicts. Drug Alcohol Depend (1985) 0.89
Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J Clin Endocrinol Metab (1992) 0.89
Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab (1999) 0.89
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol (2005) 0.89
Uterine artery velocimetry and spontaneous preterm delivery. Obstet Gynecol (1995) 0.89
Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women. Am J Obstet Gynecol (2001) 0.89
Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors. Hum Reprod (2007) 0.89
Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Am J Obstet Gynecol (1984) 0.89
Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril (1998) 0.88
Progestogens and brain: an update. Maturitas (2009) 0.88
Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. Horm Res (1983) 0.88
Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause (2001) 0.88
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma. Anticancer Res (1999) 0.87
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum (2005) 0.87
Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women. Eur J Endocrinol (1997) 0.87
Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Fertil Steril (2001) 0.87
CNS: sex steroids and SERMs. Ann N Y Acad Sci (2003) 0.87
Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum Reprod (2009) 0.87
Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications. Eur J Gynaecol Oncol (2002) 0.87
The HRT misuse and osteoporosis epidemic: a possible future scenario. Climacteric (2007) 0.87